August 22, 2012
Novartis Pharma announced on August 20 that its immunosuppressant agents Neoral and Sandimmune (ciclosporin) were approved on the same day for the prevention of organ rejection following small intestine transplantation as an additional indication. In Japan, Novartis has been marketing...read more